Moderna gets full US approval for COVID shot in at-risk children 6 months and older
Coronavirus,Coronavirus Vaccine,Vaccines,FDA
From the Center
AllSides Media Bias Rating: Center
The U.S. Food and Drug Administration has granted full approval for Moderna's (MRNA.O), opens new tab COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.
Check for Bias
The AI-powered AllSides Bias Checker instantly reveals the bias of a news article. Tap the button to use.
AllSides Picks
Red Blue Translator
Anti-vaxxer
Headline Roundup
DOJ Says Chinese Hackers Targeted US Federal Agencies
August 26th, 2026
Headline Roundup
Meta Agrees to New Facebook, Instagram Limits for Teens in $18 Million Settlement
August 26th, 2026
Bias
Announcing Version 12 of the AllSides Media Bias Chart — See What’s Changed
AllSides
August 25th, 2026
